Chemistry:Tetrahydroharmol
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | 1,2-Dihydroharmaline |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H14N2O |
| Molar mass | 202.257 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tetrahydroharmol is a bioactive beta-carboline harmala alkaloid.[1] It acts as a reversible inhibitor of monoamine oxidase A.[2]
Legal Status
Australia
Harmala alkaloids are considered Schedule 9 prohibited substances under the Poisons Standard (October 2015).[3] A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.[3]
See also
References
- ↑ "Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca". Drug Testing and Analysis 4 (7-8): 610–616. 2012. doi:10.1002/dta.1344. PMID 22514127.
- ↑ "Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity". Biochemical Pharmacology (Elsevier BV) 26 (21): 1991–1996. November 1977. doi:10.1016/0006-2952(77)90007-7. PMID 921812.
- ↑ 3.0 3.1 "Poisons Standard October 2015". Australian Government Department of Health. September 2015. https://www.comlaw.gov.au/Details/F2015L01534.
 |  |
